Both in Pharmaceuticals
Polaryx Therapeutics vs Milestone Pharmaceuticals
Over the past year PLYX returned −94.9% and MIST returned −60.8%; their daily moves had a correlation of 0.10.
PLYX −94.9% MIST −60.8%Growth of $1, one year, split-adjusted
| Metric | PLYX | MIST |
|---|---|---|
| Price | $1.80 | $0.7687 |
| Market cap | $89.7M | $95.7M |
| Today | +4.05% | +1.24% |
| 1 month | −14.3% | +0.6% |
| 6 months | −52.6% | −61.0% |
| Year to date | — | −61.9% |
| 1 year | — | −58.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 94.3% |
| Net margin | — | −5118.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 40.8× |
| Net cash | $11.5M | $111.4M |
| Dividend yield | — | — |
| Volatility (60d) | 68.1% | 74.1% |
| Short % of float | 0.8% | 17.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).